Jump to Content
ADGC
Alzheimer's Disease
Genetics Consortium
Home
ADGC Core Projects
Contact
About
Program Overview
Members
Committees
Links
Alzheimer's Disease
Acknowledgements
Collaborative Data Access (SAGs)
SAG Proposal Instructions
SAG Overview
Current ADGC Special Analysis Group Projects (SAGs)
Publications
ADGC Publications
Publications Supported by the ADGC
Publications Using ADGC and IGAP Summary Statistics
For Members
Login
You are here
Home
» ADGC Publications
ADGC Publications
Found 7 results
Filters:
Keyword
is
Amyloid beta-Peptides
and
Author
is
Cruchaga, Carlos
[Clear All Filters]
2019
Baker E
,
Sims R
,
Leonenko G
,
Frizzati A
,
Harwood JC
,
Grozeva D
,
Morgan K
,
Passmore P
,
Holmes C
,
Powell J
et al.
. 2019.
Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.
.
PLoS One. 14(7):e0218111.
2018
Deming Y
,
Dumitrescu L
,
Barnes LL
,
Thambisetty M
,
Kunkle B
,
Gifford KA
,
Bush WS
,
Chibnik LB
,
Mukherjee S
,
De Jager PL
et al.
. 2018.
Sex-specific genetic predictors of Alzheimer's disease biomarkers.
.
Acta Neuropathol. 136(6):857-872.
2017
Deming Y
,
Li Z
,
Kapoor M
,
Harari O
,
Del-Aguila JL
,
Black K
,
Carrell D
,
Cai Y
,
Fernandez MVictoria
,
Budde J
et al.
. 2017.
Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
.
Acta Neuropathol. 133(5):839-856.
2014
Kauwe JSK
,
Bailey MH
,
Ridge PG
,
Perry R
,
Wadsworth ME
,
Hoyt KL
,
Staley LA
,
Karch CM
,
Harari O
,
Cruchaga C
et al.
. 2014.
Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.
.
PLoS Genet. 10(10):e1004758.
Wetzel-Smith MK
,
Hunkapiller J
,
Bhangale TR
,
Srinivasan K
,
Maloney JA
,
Atwal JK
,
Sa SM
,
Yaylaoglu MB
,
Foreman O
,
Ortmann W
et al.
. 2014.
A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death.
.
Nat Med. 20(12):1452-7.
Ramirez A
,
van der Flier WM
,
Herold C
,
Ramonet D
,
Heilmann S
,
Lewczuk P
,
Popp J
,
Lacour A
,
Drichel D
,
Louwersheimer E
et al.
. 2014.
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.
.
Hum Mol Genet. 23(24):6644-58.
2013
Cruchaga C
,
Kauwe JSK
,
Harari O
,
Jin SChih
,
Cai Y
,
Karch CM
,
Benitez BA
,
Jeng AT
,
Skorupa T
,
Carrell D
et al.
. 2013.
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
.
Neuron. 78(2):256-68.